Your browser doesn't support javascript.
loading
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
Pinette, Ashley; McMichael, Elizabeth; Courtney, Nicholas B; Duggan, Megan; Benner, Brooke N; Choueiry, Fouad; Yu, Lianbo; Abood, David; Mace, Thomas A; Carson, William E.
Afiliação
  • Pinette A; Department of Surgery, The Ohio State University, Columbus, OH, USA.
  • McMichael E; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Courtney NB; Department of Surgery, The Ohio State University, Columbus, OH, USA.
  • Duggan M; Department of Surgery, The Ohio State University, Columbus, OH, USA.
  • Benner BN; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Choueiry F; Division of Gastroenterology, Hepatology & Nutrition, Department of Internal Medicine, The Ohio State University, 420 W 12th Ave., Columbus, OH, 43210, USA.
  • Yu L; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
  • Abood D; Division of Gastroenterology, Hepatology & Nutrition, Department of Internal Medicine, The Ohio State University, 420 W 12th Ave., Columbus, OH, 43210, USA.
  • Mace TA; Division of Gastroenterology, Hepatology & Nutrition, Department of Internal Medicine, The Ohio State University, 420 W 12th Ave., Columbus, OH, 43210, USA. thomas.mace@osumc.edu.
  • Carson WE; Department of Surgery, The Ohio State University, Columbus, OH, USA.
Cancer Immunol Immunother ; 68(8): 1379-1389, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31338557

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Carcinoma de Células Escamosas / Proteínas / Cetuximab / Neoplasias de Cabeça e Pescoço / Imunoterapia / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Carcinoma de Células Escamosas / Proteínas / Cetuximab / Neoplasias de Cabeça e Pescoço / Imunoterapia / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article